Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: rituximab

Rheumatoid Arthritis & Autoimmune Glomerulonephritis

Rheumatoid Arthritis & Autoimmune Glomerulonephritis

Diana M. Girnita, MD, PhD, Shahzad Safdar, MD, & Avis Ware, MD  |  June 13, 2016

Rheumatoid arthritis (RA) is rarely associated with renal manifestations, but secondary amyloidosis due to chronic inflammation is reported to be the etiology of renal dysfunction in many cases of RA.1,2 The discovery of biologic therapy, with TNF-alpha inhibitors in particular, made a huge difference in the disease course and prognosis of RA patients. However, TNF-alpha…

Filed under:ConditionsRheumatoid Arthritis Tagged with:Autoimmunecase reportClinicalDiagnosisGlomerulonephritisimmune complexpatient careRenalRheumatoid arthritisrheumatologyTNF-Alpha inhibitor

Diagnostic Tests, Tips for Gluten-Induced Celiac Disease

Thomas R. Collins  |  June 13, 2016

CHICAGO—Celiac disease—the gluten-induced illness that can be seen alongside rheumatic diseases—has been seen much more commonly over the past 20 years than it was previously, but the illness can come with questions that are not always straightforward, an expert said at the ACR’s State-of-the-Art Clinical Symposium. The disease, in which the small intestine becomes inflamed…

Filed under:ConditionsOther Rheumatic ConditionsResearch Rheum Tagged with:2016 State-of-the-Art Clinical SymposiumAC&RAmerican College of Rheumatology (ACR)celiac diseasegastrointestinalglutenpatient careResearchRheumatic DiseaserheumatologistrheumatologyTestTreatment

Tips on Vaccinating Patients with Rheumatic Diseases

Thomas R. Collins  |  June 13, 2016

CHICAGO—In October of last year, a 52-year-old woman came to see Kevin Winthrop, MD, MPH, associate professor in infectious diseases, public health and preventive medicine at the Oregon Health & Sciences University. She had rheumatoid arthritis and was taking methotrexate and prednisone. She had had little change in her RA disease severity and was considering…

Filed under:ConditionsPractice Support Tagged with:2016 State-of-the-Art Clinical SymposiumFluherpes zosterpatient carepneumoniaRheumatic Diseaserheumatology

Precision Medicine Latest Initiative in War on Autoimmunity, Rheumatic Illnesses

Precision Medicine Latest Initiative in War on Autoimmunity, Rheumatic Illnesses

Simon M. Helfgott, MD  |  June 12, 2016

It’s been said that there is no greater bully pulpit than the American presidency. Linking the force of moral persuasion to this most powerful office—one that is capable of issuing executive orders and bypassing the wishes of Congress or rousing public opinion in favor of or against bills that are in the process of being…

Filed under:ConditionsOpinionRheuminationsSpeak Out Rheum Tagged with:Affordable Care Act (ACA)autoimmunityObamacarePrecision MedicineRheumatic Disease

Remission of Rheumatoid Arthritis Tied to Lower Risk of Metabolic Syndrome

Reuters Staff  |  June 12, 2016

NEW YORK (Reuters Health)—Disease remission in patients with rheumatoid arthritis (RA) is associated with a lower risk of developing metabolic syndrome, according to a new study from Thailand. Researchers also found that a lower educational level was linked to a higher risk of metabolic syndrome, they report in Joint Bone Spine, online May 26. Dr….

Filed under:ConditionsRheumatoid Arthritis Tagged with:metabolic syndromeRemissionRheumatoid Arthritis (RA)rituximab

Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes

Arthritis & Rheumatology  |  June 1, 2016

A variety of immune and nonimmune pathophysiologic mechanisms causing the disruption of alveolar capillaries with bleeding into the alveolar spaces can lead to diffuse alveolar hemorrhage (DAH). Immune-mediated mechanisms can cause DAH with or without the presence of capillaritis. The antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) syndromes—granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)—are the…

Filed under:ConditionsResearch RheumVasculitis Tagged with:ANCAANCA-Associated VasculitisArthritis & RheumatologyResearch

Roche & Novartis Face Off in Biosimilar Drug Battle

John Miller  |  May 31, 2016

ZURICH (Reuters)—Switzerland’s biggest drugmakers are clashing over cheaper copies of pricey biotech drugs—one reason why Novartis is considering selling its $14 billion stake in cross-town rival Roche. With a copycat of Roche’s blood cancer drug Rituxan (rituximab) pending European approval, Novartis aims to muscle in on a share of sales that last year hit 7…

Filed under:Drug Updates Tagged with:BiosimilarsBusinessgeneric drugsNovartisRemicaderituximabRoche

Patients with Lupus: Plasmacytoid Dendritic Cells Fail to Induce Regulatory B Cells

Lara C. Pullen, PhD  |  May 9, 2016

A recent study found that plasmacytoid dentricitic cells (pDCs) control the differentiation of immature B cells into regulatory B (Breg) cells or plasmablast, depending on the concentration of IFNα. For patients with SLE, researchers found that immune regulatory feedback between pDCs and Breg cells is dysfunctional, with the exception of patients who respond to rituximab…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:B cellsInflammatory DiseaseLupussystemic lupus erythematosus (SLE)

Hidradenitis Suppurativa Can Complicate Biologic Therapy

Will Boggs, MD  |  April 13, 2016

NEW YORK (Reuters Health)—Hidradenitis suppurativa can complicate biologic therapy of chronic inflammatory diseases, according to a retrospective study from France and Belgium. Hidradenitis suppurativa (HS) often responds to treatment with biologic agents, but there have been scattered reports of patients developing HS while undergoing biologic therapy. Dr. Coline Faivre from Hôpital Edouard Herriot in Lyon,…

Filed under:Biologics/DMARDsDrug Updates Tagged with:auto-inflammatory diseasebiologic drugsBiologicsHidradenitis suppurativa

Blogging Basics Rheumatologists Should Know

Karen Appold  |  February 16, 2016

To blog or not to blog? As a rheumatologist, you may have pondered this question. Perhaps getting some insight from rheumatologists who already blog and a professional blog writer may help you find the answer. Obviously, if you devoted time to blogging you would want it to be beneficial. For Paul Sufka, MD, rheumatologist, HealthPartners,…

Filed under:Professional TopicsTechnology Tagged with:BlogsGuidelinesonlinephysicianSocial MediaTechnologytips

  • « Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 45
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences